Berta Raventós

502 total citations
19 papers, 210 citations indexed

About

Berta Raventós is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Berta Raventós has authored 19 papers receiving a total of 210 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Berta Raventós's work include COVID-19 and healthcare impacts (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Berta Raventós is often cited by papers focused on COVID-19 and healthcare impacts (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Berta Raventós collaborates with scholars based in Spain, United Kingdom and Netherlands. Berta Raventós's co-authors include Andrea Pistillo, Talita Duarte‐Salles, Edward Burn, Daniel Prieto‐Alhambra, Carlen Reyes, Elena Roel, Xintong Li, Victoria Y. Strauss, Antonella Delmestri and Eugenia Martínez‐Hernández and has published in prestigious journals such as Nature Communications, European Heart Journal and BMJ.

In The Last Decade

Berta Raventós

18 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berta Raventós Spain 9 73 55 33 28 27 19 210
Anna Freeman United Kingdom 13 101 1.4× 60 1.1× 22 0.7× 58 2.1× 21 0.8× 43 448
Uzma Ishaq Pakistan 9 113 1.5× 47 0.9× 19 0.6× 45 1.6× 27 1.0× 24 256
Asmara Malik Pakistan 9 105 1.4× 11 0.2× 8 0.2× 38 1.4× 21 0.8× 15 246
Ling Ma China 3 101 1.4× 25 0.5× 17 0.5× 26 0.9× 24 0.9× 5 310
Miaotian Cai China 7 122 1.7× 51 0.9× 13 0.4× 55 2.0× 11 0.4× 17 295
Marcarious M. Tantuoyir Iran 10 148 2.0× 37 0.7× 15 0.5× 47 1.7× 28 1.0× 19 245
Sara de la Fuente Spain 7 109 1.5× 19 0.3× 19 0.6× 101 3.6× 23 0.9× 25 222
Lumine Na Australia 8 145 2.0× 7 0.1× 54 1.6× 31 1.1× 8 0.3× 12 312
Sara Jam Iran 14 120 1.6× 45 0.8× 31 0.9× 187 6.7× 76 2.8× 24 456

Countries citing papers authored by Berta Raventós

Since Specialization
Citations

This map shows the geographic impact of Berta Raventós's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berta Raventós with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berta Raventós more than expected).

Fields of papers citing papers by Berta Raventós

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berta Raventós. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berta Raventós. The network helps show where Berta Raventós may publish in the future.

Co-authorship network of co-authors of Berta Raventós

This figure shows the co-authorship network connecting the top 25 collaborators of Berta Raventós. A scholar is included among the top collaborators of Berta Raventós based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berta Raventós. Berta Raventós is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Reyes, Carlen, Danielle Newby, Berta Raventós, et al.. (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age and Ageing. 53(5). 1 indexed citations
2.
Neto, Felippe Lazar, et al.. (2024). Effectiveness of COVID-19 vaccines against severe COVID-19 among patients with cancer in Catalonia, Spain. Nature Communications. 15(1). 5088–5088.
3.
Barclay, Nicola L., Marta Pineda‐Moncusí, Annika M. Jödicke, et al.. (2024). The impact of the UK COVID-19 lockdown on the screening, diagnostics and incidence of breast, colorectal, lung and prostate cancer in the UK: a population-based cohort study. Frontiers in Oncology. 14. 1370862–1370862. 11 indexed citations
4.
Raventós, Berta, Martí Català, Yuchen Guo, et al.. (2023). IncidencePrevalence: An R package to calculate population‐level incidence rates and prevalence using theOMOPcommon data model. Pharmacoepidemiology and Drug Safety. 33(1). e5717–e5717. 8 indexed citations
5.
Navarro, Jordi, Adrián Curran, Berta Raventós, et al.. (2023). Prevalence of non-alcoholic fatty liver disease in a multicentre cohort of people living with HIV in Spain.. European Journal of Internal Medicine. 110. 54–61. 6 indexed citations
6.
Raventós, Berta, Sergio Fernández‐Bertolín, María Aragón, et al.. (2023). Transforming the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model and Its Use for COVID-19 Research. Clinical Epidemiology. Volume 15. 969–986. 6 indexed citations
7.
Medina‐Perucha, Laura, Andrea Pistillo, Berta Raventós, et al.. (2022). Endometriosis prevalence and incidence trends in a large population-based study in Catalonia (Spain) from 2009 to 2018. Women s Health. 18. 892541254–892541254. 20 indexed citations
8.
Raventós, Berta, Andrea Pistillo, Carlen Reyes, et al.. (2022). Impact of the COVID-19 pandemic on diagnoses of common mental health disorders in adults in Catalonia, Spain: a population-based cohort study. BMJ Open. 12(4). e057866–e057866. 12 indexed citations
9.
Requena, Manuel, Ariadna Torrella, Bibiana Planas, et al.. (2022). COVID-19 Follow-App. Mobile App-Based Monitoring of COVID-19 Patients after Hospital Discharge: A Single-Center, Open-Label, Randomized Clinical Trial. Journal of Personalized Medicine. 12(1). 24–24. 4 indexed citations
10.
Burn, Edward, Elena Roel, Andrea Pistillo, et al.. (2022). Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain. Nature Communications. 13(1). 7169–7169. 13 indexed citations
11.
García, Jorge, Esperanza Cañas‐Ruano, Jordi Navarro, et al.. (2022). Sexual behavior and drug use impact in gay, bisexual, and other men who have sex with men. Medicina Clínica. 159(12). 563–568. 2 indexed citations
12.
13.
Roel, Elena, Berta Raventós, Edward Burn, et al.. (2022). Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain. Emerging infectious diseases. 28(11). 2243–2252. 10 indexed citations
14.
Raventós, Berta, et al.. (2022). Impact of the COVID‐19 pandemic on eating disorders diagnoses among adolescents and young adults in Catalonia: A population‐based cohort study. International Journal of Eating Disorders. 56(1). 225–234. 9 indexed citations
15.
Marcolino, Milena Soriano, Israel Júnior Borges do Nascimento, Adrián Sánchez‐Montalvá, et al.. (2021). Development and validation of the ABC2-SPH risk score for in-hospital mortality in COVID-19 patients. European Heart Journal. 42(Supplement_1). 1 indexed citations
16.
Astorga-Gamaza, Antonio, Judith Grau-Expósito, Joaquín Burgos, et al.. (2021). Identification of HIV-Reservoir Cells With Reduced Susceptibility to Antibody-Dependent Immune Response. SSRN Electronic Journal. 1 indexed citations
17.
Cañas‐Ruano, Esperanza, Berta Raventós, Joaquín Burgos, et al.. (2020). Incidencia de neoplasias en una cohorte española de pacientes con infección por el virus de la inmunodeficiencia humana. Medicina Clínica. 155(7). 288–294. 1 indexed citations
18.
Cañas‐Ruano, Esperanza, Berta Raventós, Joaquín Burgos, et al.. (2020). Incidence of malignancy in a Spanish cohort of patients infected by the human immunodeficiency virus. Medicina Clínica (English Edition). 155(7). 288–294. 1 indexed citations
19.
Serra‐Peinado, Carla, Judith Grau-Expósito, Antonio Astorga-Gamaza, et al.. (2019). Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab. Nature Communications. 10(1). 3705–3705. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anna Freeman Breakdown of academic impact, for papers by Uzma Ishaq Breakdown of academic impact, for papers by Asmara Malik Breakdown of academic impact, for papers by Ling Ma Breakdown of academic impact, for papers by Miaotian Cai Breakdown of academic impact, for papers by Marcarious M. Tantuoyir Breakdown of academic impact, for papers by Sara de la Fuente Breakdown of academic impact, for papers by Lumine Na Breakdown of academic impact, for papers by Sara Jam
Rankless by CCL
2026